HCPCS J9317 — Sacituzumab govitecan-hziy (2026 RVU Values)
HCPCS code J9317 (Sacituzumab govitecan-hziy) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.
HCPCS code J9317 (Sacituzumab govitecan-hziy) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.